BR0208005A - Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo - Google Patents
Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmoInfo
- Publication number
- BR0208005A BR0208005A BR0208005-2A BR0208005A BR0208005A BR 0208005 A BR0208005 A BR 0208005A BR 0208005 A BR0208005 A BR 0208005A BR 0208005 A BR0208005 A BR 0208005A
- Authority
- BR
- Brazil
- Prior art keywords
- delayed type
- type hypersensitivity
- inducer
- present
- topical
- Prior art date
Links
- 239000000853 adhesive Substances 0.000 title abstract 6
- 230000001070 adhesive effect Effects 0.000 title abstract 6
- 239000000411 inducer Substances 0.000 title abstract 6
- 238000002360 preparation method Methods 0.000 title abstract 6
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 title abstract 5
- 230000000699 topical effect Effects 0.000 title abstract 5
- 230000005951 type IV hypersensitivity Effects 0.000 title abstract 5
- 208000027930 type IV hypersensitivity disease Diseases 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 208000030507 AIDS Diseases 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
- A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"PREPARAçãO PARA ADESIVO TóPICO CONTENDO INDUTOR DE HIPERSENSIBILIDADE DO TIPO RETARDADO E PROCESSOS PARA A UTILIZAçãO DO MESMO". A invenção refere-se à preparações para adesivos tópicos que contêm um indutor de hipersensibilidade do tipo retardado, por exemplo, 1-dicloro-2,4-dinitrobenzeno (DNCB) e processos para a utilização dos mesmos. As presentes preparações para adesivos tópicos são constituídas de uma composição de gel adesivo que está presente sobre um suporte, em que a composição de gel adesivo inclui o indutor de hipersensibilidade do tipo retardado, um gel de polímero solúvel em água, água e um agente de sustentação de água. Utilizando as presentes preparações para adesivos tópicos, as preparações para adesivos tópicos são aplicadas sobre uma superfície da pele de um indivíduo e são mantidas no local de aplicação durante um período de tempo suficiente para que uma quantidade eficaz do indutor de hipersensibilidade do tipo retardado seja administrada ao indivíduo, onde este período de manutenção tipicamente não excede aproximadamente 60 minutos. A presente invenção encontra uso em uma variedade de aplicações onde a administração de um indutor de hipersensibilidade do tipo retardado é desejada e é particularmente adequada para uso no tratamento de condições de doença associadas com o HIV, por exemplo, a AIDS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27521301P | 2001-03-12 | 2001-03-12 | |
PCT/US2002/005641 WO2002072081A1 (en) | 2001-03-12 | 2002-02-22 | Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0208005A true BR0208005A (pt) | 2004-03-02 |
Family
ID=23051331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0208005-2A BR0208005A (pt) | 2001-03-12 | 2002-02-22 | Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo |
Country Status (22)
Country | Link |
---|---|
US (3) | US6761900B2 (pt) |
EP (1) | EP1370251A1 (pt) |
JP (2) | JP2004524327A (pt) |
KR (2) | KR20090117839A (pt) |
CN (1) | CN100594893C (pt) |
AU (1) | AU2002247209C1 (pt) |
BR (1) | BR0208005A (pt) |
CA (1) | CA2440209A1 (pt) |
CR (1) | CR7078A (pt) |
EA (1) | EA006208B1 (pt) |
HK (1) | HK1072364A1 (pt) |
IL (2) | IL157795A0 (pt) |
ME (1) | MEP9808A (pt) |
MX (1) | MXPA03008206A (pt) |
NO (1) | NO20033985L (pt) |
NZ (1) | NZ528098A (pt) |
PL (1) | PL363839A1 (pt) |
RS (1) | RS50729B (pt) |
TW (1) | TWI331521B (pt) |
UA (1) | UA79587C2 (pt) |
WO (1) | WO2002072081A1 (pt) |
ZA (1) | ZA200306997B (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6761900B2 (en) * | 2001-03-12 | 2004-07-13 | Teikoku Pharma Usa, Inc. | Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
US20030118632A1 (en) * | 2001-12-26 | 2003-06-26 | Larry Caldwell | Methods and compositions for treating carpal tunnel syndrome |
US7645916B2 (en) * | 2003-01-23 | 2010-01-12 | Specialty Silicone Fabricators, Inc. | Elastically deformable fabric with gel coated surface |
US20040147187A1 (en) * | 2003-01-23 | 2004-07-29 | Rasor Allen C. | Elastically deformable fabric with gel coated surface |
ITMI20030414A1 (it) * | 2003-03-06 | 2004-09-07 | Biofarm S R L Ora Biofarmitalia S P A | Tampone con strato di gel con attivita' cosmetica o terapeutica. |
US20060211766A1 (en) * | 2004-09-30 | 2006-09-21 | Kaplan Leonard L | Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections |
US8080261B2 (en) * | 2004-09-30 | 2011-12-20 | Teikoku Pharma Usa, Inc. | 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same |
AP2007003963A0 (en) * | 2004-09-30 | 2007-04-30 | Teikoku Pharma Usa Inc | 1-Chloro-2,4-dinitrobenzene gel compositions and methods for using the same |
AU2005323206C1 (en) * | 2005-01-04 | 2010-01-07 | Teikoku Pharma Usa, Inc. | Cooling topical patch preparation |
EP1940377A4 (en) * | 2005-10-24 | 2010-12-08 | Teikoku Pharma Usa Inc | TOPICAL AEROSPECTIVE COMPOSITIONS OF N, 2,3-TRIMETHYL-2-ISOPROPYLBUTAMIDE AND METHOD OF USE THEREOF |
JP5010829B2 (ja) * | 2005-12-28 | 2012-08-29 | 帝國製薬株式会社 | 貼付剤 |
JP5010834B2 (ja) * | 2006-02-20 | 2012-08-29 | 帝國製薬株式会社 | 貼付剤 |
KR101352238B1 (ko) | 2007-04-04 | 2014-01-15 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 단순포진바이러스 감염 치료를 위한 비특이적 지연형 과민증 반응 |
WO2009005814A2 (en) * | 2007-07-03 | 2009-01-08 | Marchitto Kevin S | Drug-delivery patch comprising a dissolvable layer and uses thereof |
EP3494790A1 (en) | 2010-03-02 | 2019-06-12 | Phio Pharmaceuticals Corp. | Effective sensitizing dose of a gelled immunomodulating topical composition |
EP3087985B1 (en) * | 2013-12-18 | 2018-10-17 | Maruishi Pharmaceutical Co., Ltd. | Hydrous adhesive patch |
US20160279083A1 (en) * | 2015-02-24 | 2016-09-29 | Moein Health, Inc. | Topical treatment for cervical intraepithelial neoplasia |
US10588564B2 (en) | 2014-09-30 | 2020-03-17 | Moein Health, LLC | Method and kit for diagnosing and treating neoplastic tissue |
EP3261654B1 (en) | 2015-02-26 | 2021-08-11 | Squarex, LLC | Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection |
KR101646181B1 (ko) | 2015-08-18 | 2016-08-05 | 한양대학교 에리카산학협력단 | 이리노테칸 함유 이중역상 온도감응성 수용성 겔 조성물 |
US10371610B2 (en) | 2016-02-23 | 2019-08-06 | Noul Co., Ltd. | Contact-type patch, staining method using the same, and manufacturing method thereof |
KR20170099737A (ko) | 2016-02-23 | 2017-09-01 | 노을 주식회사 | 접촉식 염색 패치 및 이를 이용하는 염색 방법 |
BR112021011103A8 (pt) * | 2018-12-18 | 2022-08-09 | Currahee Holding Company Inc | Emplastro personalizado para aplicação tópica |
CN112315661A (zh) * | 2020-10-26 | 2021-02-05 | 广东泰宝医疗科技股份有限公司 | 一种持效期长的离子感应贴 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2375861A1 (fr) | 1976-12-31 | 1978-07-28 | Merieux Inst | Tampon adhesif pour tests epicutanes |
US4129547A (en) * | 1977-06-30 | 1978-12-12 | E. I. Du Pont De Nemours And Company | High solids coating compositions for flexible substrates containing urea-formaldehyde |
US4129647A (en) | 1977-10-17 | 1978-12-12 | Edmund Klein | Treatment of acne |
US4897260A (en) * | 1987-05-22 | 1990-01-30 | The Rockefeller University | Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same |
US5476664A (en) * | 1994-04-15 | 1995-12-19 | Leonard Bloom | Treatment of warts using anthralins and occlusion |
DE69524614T2 (de) * | 1994-10-05 | 2002-09-12 | Hisamitsu Pharmaceutical Co | Arzneimittelbestandteile einschliesslich eines n-substituierten o-toluidinderivats und transdermal absorbierbare zubereitung |
AU5543196A (en) * | 1995-04-12 | 1996-10-30 | Robert B. Hopp | Skin patch for use in contact immunotherapy |
JPH11171768A (ja) | 1997-10-15 | 1999-06-29 | Taisho Pharmaceut Co Ltd | 消炎鎮痛外用剤 |
WO2001047559A1 (fr) | 1999-12-27 | 2001-07-05 | Teikoku Seiyaku Co., Ltd | Pastilles a usage externe |
US6761900B2 (en) * | 2001-03-12 | 2004-07-13 | Teikoku Pharma Usa, Inc. | Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
-
2002
- 2002-02-21 US US10/080,526 patent/US6761900B2/en not_active Expired - Fee Related
- 2002-02-22 PL PL02363839A patent/PL363839A1/xx not_active Application Discontinuation
- 2002-02-22 KR KR1020097020935A patent/KR20090117839A/ko not_active Application Discontinuation
- 2002-02-22 CA CA002440209A patent/CA2440209A1/en not_active Abandoned
- 2002-02-22 IL IL15779502A patent/IL157795A0/xx active IP Right Grant
- 2002-02-22 WO PCT/US2002/005641 patent/WO2002072081A1/en active Application Filing
- 2002-02-22 ME MEP-98/08A patent/MEP9808A/xx unknown
- 2002-02-22 AU AU2002247209A patent/AU2002247209C1/en not_active Ceased
- 2002-02-22 UA UA2003098465A patent/UA79587C2/uk unknown
- 2002-02-22 RS YUP-707/03A patent/RS50729B/sr unknown
- 2002-02-22 KR KR10-2003-7011955A patent/KR20030088457A/ko active Search and Examination
- 2002-02-22 BR BR0208005-2A patent/BR0208005A/pt active Search and Examination
- 2002-02-22 NZ NZ528098A patent/NZ528098A/en not_active IP Right Cessation
- 2002-02-22 EA EA200300995A patent/EA006208B1/ru not_active IP Right Cessation
- 2002-02-22 JP JP2002571040A patent/JP2004524327A/ja active Pending
- 2002-02-22 CN CN02809677A patent/CN100594893C/zh not_active Expired - Fee Related
- 2002-02-22 EP EP02714984A patent/EP1370251A1/en not_active Withdrawn
- 2002-02-22 MX MXPA03008206A patent/MXPA03008206A/es active IP Right Grant
- 2002-03-11 TW TW091104442A patent/TWI331521B/zh not_active IP Right Cessation
-
2003
- 2003-09-07 IL IL157795A patent/IL157795A/en not_active IP Right Cessation
- 2003-09-08 ZA ZA200306997A patent/ZA200306997B/en unknown
- 2003-09-09 NO NO20033985A patent/NO20033985L/no not_active Application Discontinuation
- 2003-09-18 CR CR7078A patent/CR7078A/es unknown
-
2004
- 2004-05-28 US US10/856,963 patent/US20040219199A1/en not_active Abandoned
- 2004-05-28 US US10/857,773 patent/US20040219200A1/en not_active Abandoned
-
2005
- 2005-06-15 HK HK05105016.4A patent/HK1072364A1/xx not_active IP Right Cessation
-
2009
- 2009-09-10 JP JP2009209575A patent/JP2010013474A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NZ528098A (en) | 2004-04-30 |
KR20030088457A (ko) | 2003-11-19 |
UA79587C2 (en) | 2007-07-10 |
JP2004524327A (ja) | 2004-08-12 |
RS50729B (sr) | 2010-08-31 |
JP2010013474A (ja) | 2010-01-21 |
MXPA03008206A (es) | 2004-11-12 |
CN100594893C (zh) | 2010-03-24 |
US20040219200A1 (en) | 2004-11-04 |
IL157795A0 (en) | 2004-03-28 |
TWI331521B (en) | 2010-10-11 |
MEP9808A (en) | 2010-06-10 |
CR7078A (es) | 2004-03-10 |
EA200300995A1 (ru) | 2004-02-26 |
KR20090117839A (ko) | 2009-11-12 |
CN1561202A (zh) | 2005-01-05 |
WO2002072081A1 (en) | 2002-09-19 |
HK1072364A1 (en) | 2005-08-26 |
EP1370251A1 (en) | 2003-12-17 |
NO20033985D0 (no) | 2003-09-09 |
CA2440209A1 (en) | 2002-09-19 |
IL157795A (en) | 2007-08-19 |
AU2002247209B2 (en) | 2005-11-17 |
ZA200306997B (en) | 2004-09-08 |
PL363839A1 (en) | 2004-11-29 |
US6761900B2 (en) | 2004-07-13 |
NO20033985L (no) | 2003-11-03 |
US20040219199A1 (en) | 2004-11-04 |
US20020176886A1 (en) | 2002-11-28 |
EA006208B1 (ru) | 2005-10-27 |
AU2002247209C1 (en) | 2006-08-10 |
YU70703A (sh) | 2006-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0208005A (pt) | Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo | |
BR9911071A (pt) | Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido | |
BR9806470B1 (pt) | preparação do tipo absorção percutánea. | |
TW200637529A (en) | Topical patch cooling preparation and methods for using the same | |
BR9911076A (pt) | Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica | |
BRPI0510428A (pt) | composições tópicas de metadona e processos para utilização das mesmas | |
BR9715022A (pt) | Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada | |
JP2004505007A5 (pt) | ||
DE60313597D1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
BR0214344A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
DE69833000D1 (de) | Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen | |
DK1009393T3 (da) | Transdermalt, terapeutisk system med hæfteklæbende reservoirlag og bagsidelag, som er elastisk i én retning | |
BR0013771A (pt) | Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica | |
WO2004078122A3 (en) | Invisible patch for active agnet controlled delivery | |
CO4410203A1 (es) | Formulaciones de analogos de insulina | |
BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
BR0317177A (pt) | Preparações de liberação controlada compreendendo tramadol e topiramato | |
JP2004524327A5 (pt) | ||
NO20006430L (no) | Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner | |
DE50114474D1 (de) | Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen | |
BR9904613A (pt) | Utilização de uma goma de silicone, composição tópica e utilização de uma composição | |
BR9813514A (pt) | Agente para tratamento de fibras queratìnicas | |
BR0310061A (pt) | Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições | |
BR0316463A (pt) | Administração dérmica de um inibidor seletivo de ciclooxigenase-2 solúvel em água, por exemplo, derivados de parecoxib, valdecoxib e benzopirano | |
BR0008192A (pt) | Emplastros tipo folha |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 14A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2364 DE 26-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B07F | Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette] |